Prostate News Archive
11-Dec-2007
Beyond The Abstract Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy In Treatment Of Prostate Cancer (Medical News Today)
UroToday.com - Pituitary apoplexy can occur after administration of gonadotropin releasing hormone agonist (GnRHa) for treatment in patients with prostate cancer. Patients may present with sudden headache, visual deficits, altered mental status, and nausea. Although rare, it is generally thought to be due to hemorrhage or infarction in a previously silent pituitary tumor. [click link for full ... Growth factor receptor affects prostate cancer progression (EurekAlert!)
Breeding mice with a gene for a cellular receptor that can be turned on and off-at will-not only enabled researchers at Baylor College of Medicine in Houston to show how prostate cancer progresses, but also provides a model for studying when a drug targeting a gene will have an effect on the cancer. Better grades for prostate health in Alabama (The Daily Comet)
BIRMINGHAM, Ala. Two years ago - when Alabama was one of five states to earn an "F" on a national prostate health ranking - Birmingham urologist Thomas Moody first shrugged it off as yet another disappointing Alabama statistic. Late Breaking Developments In Transitional Prostate Cancer (Medical News Today)
UroToday.com - Three late breaking development papers were presented in the field of prostate cancer."Predicting the need for treatment among men with low grade, low stage prostatic cancer enrolled in a program of expectant management with curative intent"Dr. Danil Markarove said that some CaP have a long natural history. [click link for full article]
Back to Prostate News Archive
